A cross-sectional survey of hepatitis B virus screening in patients who received immunosuppressive therapy for rheumatoid arthritis in Japan

Table 3 Factors affecting HBV screening identified by multivariate logistic regression analysis

Characteristics	Odds ratio	95% CI	p-value
Male	1.26	1.21-1.33	<.0001*
Hospitalisation	0.70	0.65-0.75	<.0001*
Hospital department	1.05	1.01-1.10	0.0267*
csDMARDs	0.88	0.73-1.07	0.1950
bDMARDs	0.46	0.27-0.80	0.0048*
tsDMARDs (Reference)	1.00	-	-
Steroid	1.45	1.38-1.52	<.0001*
Injection	1.53	0.91-2.55	0.1064

^*Results with p-values ≤ 0.05 were considered statistically significant. HBV Hepatitis B virus, DMARDs disease-modifying antirheumatic drugs, csDMARDs Conventional synthetic DMARDs, bDMARDs biological DMARDs, tsDMARDs Targeted synthetic DMARDs

ISSN: 2055-0294